Differential roles for CD4 and CD8 T cells after diisocyanate sensitization: Genetic control of TH2-induced lung inflammation

Journal of Allergy and Clinical Immunology

Volumn 111, Issue 5, 2003, Pages 1087-1094

  Herrick, Christina A ^a   Das, Jyoti ^a   Xu, Lan ^a   Wisnewski, Adam V ^a   Redlich, Carrie A ^a   Bottomly, Kim ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Airway; Asthma; Contact hypersensitivity; Diisocyanate; Eosinophils; Skin

Indexed keywords

ANTIBODY; CD4 ANTIGEN; CD8 ANTIGEN; HEXAMETHYLENE DIISOCYANATE; INTERLEUKIN 13; INTERLEUKIN 5;

ALLERGIC ASTHMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ARTICLE; CONTACT ALLERGY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EAR; GENETIC REGULATION; INFLAMMATION; LYMPH NODE; MOUSE; MOUSE STRAIN; NONHUMAN; OCCUPATIONAL ASTHMA; PRIORITY JOURNAL; SENSITIZATION; T LYMPHOCYTE; TH2 CELL;

EID: 0037728875     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2003.1413     Document Type: Article

References (42)

1. Redlich CA, Karol MH. Diisocyanate asthma: clinical aspects and immunopathogenesis. Int Immunopharmacol 2002;2:213-24.
2. Wisnewski AV, Redlich CA. Recent developments in diisocyanate asthma. Curr Opin Allergy Clin Immunol 2001;1:169-75.
3. Chan-Yeung M, Malo JL. Occupational asthma. N Engl J Med 1995;333:107-12.
4. Bernstein JA. Overview of diisocyanate occupational asthma. Toxicology 1996;111:181-9.
5. Hnizdo E, Esterhuizen TM, Rees D, Lalloo UG. Occupational asthma as identified by the Surveillance of Work-related and Occupational Respiratory Diseases programme in South Africa. Clin Exp Allergy 2001;31:32-9.
6. Busse WW, Lemanske RF Jr. Asthma. N Engl J Med 2001;344:350-62.
7. Humbert M, Durham SR, Ying S, Kimmitt P, Barkans J, Assoufi B, et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996;154:1497-504.
8. Bentley AM, Durham SR, Kay AB. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Investig Allergol Clin Immunol 1994;4:222-32.
9. Mapp C, Boschetto P, Miotto D, De Rosa E, Fabbri LM. Mechanisms of occupational asthma. Ann Allergy Asthma Immunol 1999;83:645-64.
10. Baur X, Seemann U, Marczynski B, Chen Z, Raulf-Heimsoth M. Humoral and cellular immune responses in asthmatic isocyanate workers: report of two cases. Am J Ind Med 1996;29:467-73.
11. Butcher BT, O'Neil CE, Reed MA, Salvaggio JE. Radioallergosorbent testing of toluene diisocyanate-reactive individuals using p-tolyl isocyanate antigen. J Allergy Clin Immunol 1980;66:213-6.
12. Cullinan P. Occupational asthma, IgE and IgG. Clin Exp Allergy 1998;28:668-70.
13. Bernstein DI, Jolly A. Current diagnostic methods for diisocyanate induced occupational asthma. Am J Ind Med 1999;36:459-68.
14. Lushniak BD, Reh CM. Bernstein DI, Gallagher JS. Indirect assessment of 4,4′-diphenylmethane diisocyanate (MDI) exposure by evaluation of specific humoral immune responses to MDI conjugated to human serum albumin. Am J Ind Med 1998;33:471-7.
15. Redlich CA, Stowe MH, Wisnewski AV, Eisen EA, Karol MH, Lemus R, et al. Subclinical immunologic and physiologic responses in hexamethylene diisocyanate-exposed auto body shop workers. Am J Ind Med 2001;39:587-97.
16. Lummus ZL, Alam R, Bernstein JA, Bernstein DI. Diisocyanate antigen-enhanced production of monocyte chemoattractant protein-1, IL-8, and tumor necrosis factor-alpha by peripheral mononuclear cells of workers with occupational asthma. J Allergy Clin Immunol 1998;102:265-74.
17. Fabbri LM, Boschetto P, Zocca E, Milani G, Pivirotto F, Plebani M, et al. Bronchoalveolar neutrophilia during late asthmatic reactions induced by toluene diisocyanate. Am Rev Respir Dis 1987;136:36-42.
18. Park H, Jung K, Kim H, Nahm D, Kang K. Neutrophil activation following TDI bronchial challenges to the airway secretion from subjects with TDI-induced asthma. Clin Exp Allergy 1999;29:1395-401.
19. Finotto S, Fabbri LM, Rado V, Mapp CE, Maestrelli P. Increase in numbers of CD8 positive lymphocytes and eosinophils in peripheral blood of subjects with late asthmatic reactions induced by toluene diisocyanate. Br J Ind Med 1991;48:116-21.
20. Maestrelli P, Del Prete GF, De Carli M, D'Elios MM, Saetta M, Di Stefano A, et al. CD8 T-cell clones producing interleukin-5 and interferon-gamma in bronchial mucosa of patients with asthma induced by toluene diisocyanate. Scand J Work Environ Health 1994;20:376-81.
21. Petsonk EL, Wang ML, Lewis DM, Siegel PD, Husberg BJ. Asthma-like symptoms in wood product plant workers exposed to methylene diphenyl diisocyanate. Chest 2000;118:1183-93.
22. Liu Y, Sparer J, Woskie SR, Cullen MR, Chung JS, Holm CT, et al. Qualitative assessment of isocyanate skin exposure in auto body shops: a pilot study. Am J Ind Med 2000;37:265-74.
23. Herrick CA, Xu L, Wisnewski AV, Das J, Redlich CA, Bottomly K. A novel mouse model of diisocyanate-induced asthma showing allergic-type inflammation in the lung after inhaled antigen challenge. J Allergy Clin Immunol 2002;109:873-8.
24. Chang CH, Guerder S, Hong SC, van Ewijk W, Flavell RA. Mice lacking the MHC class II transactivator (CIITA) show tissue- specific impairment of MHC class II expression. Immunity 1996;4:167-78.
25. Rattray NJ, Botham PA, Hext PM, Woodcock DR, Fielding I, Dearman RJ, et al. Induction of respiratory hypersensitivity to diphenylmethane 4,4′-diisocyanate (MDI) in guinea pigs. Influence of the route of exposure. Toxicology 1994;88:15-30.
26. Herrick CA, MacLeod H, Glusac E, Tigelaar RE, Bottomly K. Th2 responses induced by epicutaneous or inhalational protein exposure are differentially dependent on IL-4. J Clin Invest 2000;105:765-75.
27. Levin D, Constant S, Pasqualini T, Flavell R, Bottomly K. Role of dendritic cells in the priming of CD4+ T lymphocytes to peptide antigen in vivo. J Immunol 1993;151:6742-50.
28. Gocinski BL, Tigelaar RE. Roles of CD4+ and CD8+ T cells in murine contact sensitivity revealed by in vivo monoclonal antibody depletion. J Immunol 1990;144:4121-8.
29. Wang B, Fujisawa H, Zhuang L, Freed I, Howell BG, Shahid S, et al. CD4+ Th1 and CD8+ type 1 cytotoxic T cells both play a crucial role in the full development of contact hypersensitivity. J Immunol 2000;165:6783-90.
30. Kimber I, Dearman RJ. Allergic contact dermatitis: the cellular effectors. Contact Dermatitis 2002;46:1-5.
31. Schwarze J, Cieslewicz G, Joetham A, Ikemura T, Hamelmann E, Gelfand EW. CD8 T cells are essential in the development of respiratory syncytial virus-induced lung eosinophilia and airway hyperresponsiveness. J Immunol 1999;162:4207-11.
32. Hamelmann E, Oshiba A, Paluh J, Bradley K, Loader J, Potter TA, et al. Requirement for CD8+ T cells in the development of airway hyperresponsiveness in a marine model of airway sensitization. J Exp Med 1996;183:1719-29.
33. Koller BH, Marrack P, Kappler JW, Smithies O. Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science 1990;248:1227-30.
34. Cohn L, Homer RJ, Marinov A, Rankin J, Bottomly K. Induction of airway mucus production By T helper 2 (Th2) cells: a critical role for interleukin 4 in cell recruitment but not mucus production. J Exp Med 1997;186:1737-47.
35. van Rijt LS, Lambrecht BN. Role of dendritic cells and Th2 lymphocytes in asthma: lessons from eosinophilic airway inflammation in the mouse. Microsc Res Tech 2001;53:256-72.
36. Wills-Karp M, Ewart SL. The genetics of allergen-induced airway hyperresponsiveness in mice. Am J Respir Crit Care Med 1997;156:S89-96.
37. Zhang Y, Lamm WJ, Albert RK, Chi EY, Henderson WR Jr, Lewis DB. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 1997;155:661-9.
38. Morokata T, Ishikawa J, Ida K, Yamada T. C57BL/6 mice are more susceptible to antigen-induced pulmonary eosinophilia than BALB/c mice, irrespective of systemic T helper I/T helper 2 responses. Immunology 1999;98:345-51.
39. Cohn L, Herrick C, Niu N, Homer R, Bottomly K. IL-4 promotes airway eosinophilia by suppressing IFN-gamma production: defining a novel role for IFN-gamma in the regulation of allergic airway inflammation. J Immunol 2001;166:2760-7.
40. Bignon JS, Aron Y, Ju LY, Kopferschmitt MC, Garnier R, Mapp C, et al. HLA class II alleles in isocyanate-induced asthma. Am J Respir Crit Care Med 1994;149:71-5.
41. Balboni A, Baricordi OR, Fabbri LM, Gandini E, Ciaccia A, Mapp CE. Association between toluene diisocyanate-induced asthma and DQBI markers: a possible role for aspartic acid at position 57. Eur Respir J 1996;9:207-10.
42. Mapp CE, Beghe B, Balboni A, Zamorani G, Padoan M, Jovine L, et al. Association between HLA genes and susceptibility to toluene diisocyanate-induced asthma. Clin Exp Allergy 2000;30:651-6.